Leaders in Oncology Care

Professor John Gribben

MD, DSc, FRCPath, FRCP FMedSci

Professor John Gribben graduated from the University of Glasgow in 1980. He subsequently trained in Haematology at University College London and in Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School, where he remained on the faculty for 17 years before returning to the UK. He is both an accredited physician and a medical oncologist. He specialises in haematolgical cancers including lymphomas, leukaemias and bone marrow transplantation.

Author of more than 300 articles and chapters in peer-reviewed publications, he has a global reputation for his work in researching new drugs and forms of cancer treatment. He has grant funding from The National Cancer Institute and Cancer Research UK for pioneering studies in leukaemia and lymphoma. He has sat on or chaired numerous international executive committees dedicated to investigating new approaches to cancer care, and several of the editorial boards for professional publications which are focused on cancer. He has recently been appointed an Editor of Blood. He has lectured across the world on new therapies for cancer treatment.